胶质母细胞瘤中的 CAR-T 细胞治疗：从 αβ 到 γδ T 细胞平台
CAR-T cell therapy in glioblastoma: from αβ to γδ T-cell platforms.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
FRONTIER PAPERS
前沿论文 12
近 5 年肿瘤细胞治疗领域的研究论文。默认按评分排序（权威性 + 新鲜度）。
利用先进制造与基因工程改造 γδ T 细胞用于肿瘤免疫治疗
Re-Tooling of γδ T Cells for Cancer Immunotherapy Using Advanced Manufacturing and Genetic Engineering.
评述："PSCA CAR 工程化 Vδ1 γδ T 细胞用于胰腺癌免疫治疗的疗效与安全性比较"
Commentary on "Comparative efficacy and safety of PSCA CAR-engineered Vδ1 γδ T cells for immunotherapy of pancreatic cancer".
推进实体瘤 CAR 细胞疗法：挑战、治疗策略和展望
Advancing CAR-based cell therapies for solid tumours: challenges, therapeutic strategies, and perspectives.
EphA2 和磷酸抗原介导的 γδT 细胞对髓母细胞瘤的选择性杀伤保留神经元和干细胞完整性
EphA2 and phosphoantigen-mediated selective killing of medulloblastoma by γδT cells preserves neuronal and stem cell integrity.
不寻常的搭档：基于 γδ-TCR 的 T 细胞治疗联合溶瘤病毒治疗弥漫性中线胶质瘤
Unusual Partners: γδ-TCR-Based T Cell Therapy in Combination with Oncolytic Virus Treatment for Diffuse Midline Gliomas.
γδ CAR 与 TRuC T 细胞的潜力：一项被发掘的宝藏
The potential of γδ CAR and TRuC T cells: An unearthed treasure.
以嵌合抗原受体武装 Vδ2 T 细胞抗击肿瘤
Arming Vδ2 T Cells with Chimeric Antigen Receptors to Combat Cancer.
颗粒酶 B 激活的 IL18 以肿瘤依赖的方式增强αβ和γδ CAR-T 细胞免疫治疗
Granzyme B-activated IL18 potentiates αβ and γδ CAR T cell immunotherapy in a tumor-dependent manner.
AML 患者在接受 allo-HCT 后的缓解状态与一种独特的单细胞骨髓 T 细胞特征相关
The remission status of AML patients after allo-HCT is associated with a distinct single-cell bone marrow T-cell signature.